Management of Venous Thromboembolism

Primary Care - Clinics in Office Practice

Volumn 40, Issue 1, 2013, Pages 73-90

  Burnett, Bruce ^a  

^a PARK NICOLLET INSTITUTE   (United States)

Author keywords

Anticoagulation therapy; Deep vein thrombosis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; D DIMER; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN;

ANTICOAGULANT THERAPY; CEREBRAL SINUS THROMBOSIS; CLINICAL EVALUATION; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; DRUG APPROVAL; HUMAN; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG ANGIOGRAPHY; LUNG DISEASE; LUNG EMBOLISM; MESENTERIC VEIN THROMBOSIS; OUTPATIENT CARE; PATHOGENESIS; PATIENT MONITORING; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; SECONDARY PREVENTION; THROMBOPHILIA; TREATMENT DURATION; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DIAGNOSTIC IMAGING; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; PHYSICAL EXAMINATION; POSTTHROMBOTIC SYNDROME; PULMONARY EMBOLISM; RISK FACTORS; VEINS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84873589712     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2012.11.004     Document Type: Review

References (49)

1. Anderson F.A., Wheeler H.B., Golberg R.J., et al. A population based perspective of the hospital incidence and case fatality rates of deep vein thrombosis and pulmonary embolism; the Worcester DVT Study. Arch Intern Med 1991, 151:933-938.
2. Nordström M., Lindblad B., Bergqvist D., et al. A prospective study of the incidence of deep vein thrombosis within a defined urban population. J Intern Med 1992, 232:155-160.
3. Guyatt G.H., Eikelboom J.W., Gould M.K., et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):e185S-e194S.
4. Kearon C., Akl E.A., Comerota A.J., et al. Antithrombotic therapy for VTE disease. Chest 2012, 141(Suppl 2):e419S-e494S.
5. Virchow R. Gesammalte Abhandlungen zur wissenschaftlichen Medtzin 1856, Medinger Sohn, Frankfurt (Germany), p. 219-732.
6. Heit J.A., O'Fallon W.M., Petterson T.M., et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002, 162(11):1245-1248.
7. Rosendaal F.R. Risk factors for venous thrombosis: prevalence, risk and interaction. Semin Hematol 1997, 34:171-187.
8. Rosendaal F.R., Vessey M., Rumley A., et al. Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 2002, 116:851-854. 10.1046/j.0007-1048.2002.03356.
9. Vandenbroucke J.P., Koster T., Briët E., et al. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994, 344:1453-1457.
10. Hirsh J., Hull R.D., Rashkob G.E. Clinical features and diagnosis of venous thrombosis. J Am Coll Cardiol 1986, 8:114B-127B.
11. Wells P.S., Anderson D.R., Rodger M., et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003, 349:1227-1235.
12. Wells P.S., Anderson D.R., Rodger M.A., et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer. Ann Intern Med 2001, 135(2):98-107.
13. Wells P.S. Integrated strategies for the diagnosis of venous thomboembolism. J Thromb Haemost 2007, 5(Suppl 1):41-50.
14. Stein P.D., Hull R.D., Patel K.C., et al. D dimer for the exclusion of acute venous thromboembolism: a systemic review. Ann Intern Med 2004, 140:589-602.
15. Polak J.F., Culter S.S., O'Leary D.H. Deep veins of the calf: assessment with color Doppler flow imagery. Radiology 1989, 171:481-485.
16. Lensing A.N., Prandoni P., Brandjes D., et al. Detection of deep vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989, 320:342-345.
17. Cogo A., Lensing A.W., Koopman M.M., et al. Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. Br Med J 1998, 320:324-325.
18. Simons G.R., Skibo L.K., Polak J.F., et al. Utility of leg ultrasound in suspected symptomatic isolated calf thrombosis. Am J Med 1995, 99:43-47.
19. Hayashino Y.E. Ventilation perfusion scan and helical CT in suspected pulmonary embolism: meta-analysis of diagnostic performance. Radiology 2005, 234:740-748.
20. Perrier A. Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med 2005, 352:1760-1768.
21. Fazel R., Froehlich J.B., Williams D.M., et al. Clinical problem-solving. A sinister development-a 35-year-old woman presented to the emergency department with a 2-day history of progressive swelling and pain in her left leg, without antecedent trauma. N Engl J Med 2007, 357(1):53.
22. White R.H. The epidemiology of venous thromboembolism. Circulation 2003, 107:I4-I8.
23. Chopra N., Doddamreddy P., Grewal H., et al. An elevated D-dimer value: a burden on our patients and hospitals. Int J Gen Med 2012, 5:87-92.
24. Machleder H. Neurovascular compression syndromes of the thoracic outlet. Vascular medicine 1996, 1187-1208. Little, Brown, Boston. J. Lascalzo, M. Creager, V. Dzau (Eds.).
25. Prandoni P., Poliisterna P., Bernardi E., et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis and complications. Arch Intern Med 1997, 157:57-62.
26. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005, 352:1791-1798.
27. Llach F., Papper S., Massery S.C. The clinical spectrum of renal vein thrombosis, acute and chronic. Am J Med 1980, 69:819-827.
28. Barritt D.W., Jordan S.C. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960, 1(7138):1309-1312.
29. Gould M.K., Dembitzer A.D., Doyle R.L., et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999, 130(10):800.
30. Büller H.R., Davidson B.L., Decousus H., et al. Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004, 140(11):867-873.
31. Büller H.R., Davidson B.L., Decousus H., et al. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003, 349(18):1695-1702.
32. Lee A.Y. The effects of low molecular weight heparins on venous thromboembolism and survival in patients with cancer. Thromb Res 2007, 120(Suppl 2):S121-S127.
33. Decousus H., Prandoni P., Misimetti P., Calisto Study Group, et al. Fondaparinux for the treatment of superficial vein thrombosis in the legs. N Engl J Med 2010, 363(13):1222-1232.
34. Lozanno F.S., Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vasc Endovascular Surg 2003, 37(6):415-420.
35. Boccalon H., Elias A., Chailé J.J., et al. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with low-molecular weight heparin. The Vascular Midi-Pyrenees Study. Arch Intern Med 2000, 16012:1769-1773.
36. Aujesky D., Roy P.M., Verschuren F., et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open label, randomized, noninferiority trial. Lancet 2011, 378:41-48.
37. Koopman M.M., Prandoni P., Plovella F., et al. The Tasman Study Group treatment of deep vein thrombosis with intravenous unfractionated heparin in the hospital as compared with low molecular weight heparin administered at home. N Engl J Med 1996, 334(11):682-687.
38. Carrier M., Rodger M.A., Wells P.S., et al. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systemic review and meta-analysis. J Thromb Haemost 2011, 9:119-125.
39. Stain M., Schonauer V., Minar E., et al. The post thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemost 2005, 3(12):2671-2676.
40. Brandjes D.P., Buller H.R., Heijboer H., et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997, 349(9054):759-762.
41. Prandoni P., Lensing A.W., Prims M.H., et al. Below the knee elastic compression stockings to prevent the post thrombotic syndrome; a randomized, controlled trial. Ann Intern Med 2004, 141(4):249-256.
42. Kahn S.R., Shrier I., Kearon C. Physical activity in patients with deep vein thrombosis: a systemic review. Thromb Res 2008, 122(6):763-773.
43. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125(1):1-7.
44. Palareti G., Cosmi B., Legnani C., et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006, 355(17):1780-1789.
45. Crowther M.A., Kelton J.G. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med 2003, 138(2):128-134.
46. Becattini C., Agnelli G., Schenone A., et al. Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 2012, 366:1959-1967.
47. The EINSTEIN-PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012, 366:1287-1297.
48. The EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010, 363:2499-2510.
49. Schulman S., Kearon C., Kakkar A.K., et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009, 361:2342-2352.